Rosacea Support Community

so Galderma appears to be now designating Sansrosa as CD07805/47.

Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic Rosacea

The clinical trials site is listing a dose finding trial for a topical gel that treats the redness of rosacea.

Even though the site doesn't mention COL-118 or Sansrosa by name it is clear that this is the final stages of the approval process for Sansrosa.

The aim of the trial is find the dosages that will be released to the public. Based on the efficacy of 3 strenghts, vs. just the vehicle gel Galderma will make a final application to gain approval for Sansrosa (or whatever they end up calling it).

I would imagine that sansrosa is a very tempting name as it is cute and smart and would be perfect for their branding.

Read more about Sansrosa, my extensive ongoing coverage.

davidp.

Hi, I noticed that this trial has now been "completed".

http://clinicaltrials.gov/ct2/show/NCT00989014

I am curious as to where you heard that this was the final trial and that a release would likely come in 2010 (as indicated on your blog)?

I ask because the trial phase listed on the link above is only Phase II, which would mean that they would still need to do Phase III trials. But it seems like they have been stuck in Phase II tirals for years, so are you perhaps indicating that this most recent study was in fact the Phase III trial?

Thanks for the info.

Actually, now I am really confused because they already did a Phase II dose-finding study that was completed in August, 2007!?

http://www.businesswire.com/portal/site ... ewsLang=en

So why would they do another dose-finding study in September of 2009 that was recently completed in December 2009? Unless this is a Phase III and the Phase II listed is an error?

Thoughts?